Market Cap : 123.7 B | Enterprise Value : 137.88 B | PE Ratio : 24.95 | PB Ratio : 2.35 |
---|
NYSE:MDT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:MDT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Medtronic's average Accounts Receivable for the three months ended in Apr. 2022 was $5,499 Mil. Medtronic's Revenue for the three months ended in Apr. 2022 was $8,089 Mil. Hence, Medtronic's Days Sales Outstanding for the three months ended in Apr. 2022 was 62.03.
The historical rank and industry rank for Medtronic's Days Sales Outstanding or its related term are showing as below:
During the past 13 years, Medtronic's highest Days Sales Outstanding was 82.89. The lowest was 61.25. And the median was 69.57.
Medtronic's Days Sales Outstanding increased from Apr. 2021 (59.49) to Apr. 2022 (62.03).
The historical data trend for Medtronic's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medtronic's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Medtronic's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Accounts Receivable can be measured by Days Sales Outstanding.
Medtronic's Days Sales Outstanding for the fiscal year that ended in Apr. 2022 is calculated as
Days Sales Outstanding (A: Apr. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Apr. 2021 ) | + | Accounts Receivable (A: Apr. 2022 )) | / | count ) | / | Revenue (A: Apr. 2022 ) | * | Days in Period |
= | ( (5462 | + | 5551) | / | 2 ) | / | 31686 | * | 365 |
= | 5506.5 | / | 31686 | * | 365 | ||||
= | 63.43 |
Medtronic's Days Sales Outstanding for the quarter that ended in Apr. 2022 is calculated as:
Days Sales Outstanding (Q: Apr. 2022 ) | |||||||||
= | Average Accounts Receivable | / | Revenue | * | Days in Period | ||||
= | ( (Accounts Receivable (A: Jan. 2022 ) | + | Accounts Receivable (A: Apr. 2022 )) | / | count ) | / | Revenue (A: Apr. 2022 ) | * | Days in Period |
= | ( (5446 | + | 5551) | / | 2 ) | / | 8089 | * | 365 / 4 |
= | 5498.5 | / | 8089 | * | 365 / 4 | ||||
= | 62.03 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Thank you for viewing the detailed overview of Medtronic's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Fong Ivan K | officer: EVP GENERAL COUNSEL & SECR | 3M CENTER ST. PAUL MN 55144-1000 |
Kirk Jennifer M | officer: Chief Accounting Officer | 5 GREENWAY PLAZA SUITE 110 HOUSTON TX 77046 |
Lofton Kevin E | director | GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404 |
Wall Brett A. | officer: EVP & Group Pres Restora Thera | 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 |
Salmon Sean | officer: EVP & Group President Diabetes | MEDTRONIC PLC, 710 MEDTRONIC PARKWAY LC300 MINNEAPOLIS MN 55432 |
Goldsmith Andrea Jo | director | 1220 AUGUSTA DRIVE SUITE 600 HOUSTON TX 77057 |
Liddicoat John R | officer: EVP & President of Americas | MEDTRONIC PLC 710 MEDTRONIC PKWY, MS LC300 MINNEAPOLIS MN 55432 |
White Robert John | officer: EVP & President MITG | MEDTRONIC PLC 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
Parkhill Karen L | officer: EVP & Chief Financial Officer | 1717 MAIN STREET, MC 6402 DALLAS TX 75201 |
Reddy Preetha | director | APOLLO HOSPITALS 21 GREAMS LN, OFF GREAMS RD CHENNAI K7 600006 |
Ellis Gary Lee | officer: EVP & Chief Financial Officer | THE TORO COMPANY 8111 LYNDALE AVENUE SOUTH BLOOMINGTON MN 55420 |
Hanson Bryan C | officer: EVP AND PRESIDENT, COVIDIEN | ZIMMER BIOMET HOLDINGS 345 E. MAIN STREET WARSAW IN 46580 |
Hakami Hooman | officer: EVP & Group President Diabetes | 710 MEDTRONIC PKWY MSLC300 MINNEAPOLIS MN 55432 |
Oconnell Christopher J | officer: See Remarks | MEDTRONIC, INC. 710 MEDTRONIC PKWY MINNEAPOLIS MN 55432 |
Lenehan James T | director | C/O MEDTRONIC INC 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 |
From GuruFocus
Other Sources
By Zacks 2022-02-22
By tipranks.com 2022-03-21
By Zacks 2022-03-07
By Zacks 2022-02-22
By Zacks 2022-04-01
By Zacks 2022-03-24
By Fool 2022-03-02
By tipranks.com 2022-03-10
By Zacks 2022-03-18
By Zacks 2022-03-10
By Zacks 2022-03-07
By Zacks 2022-03-21
By Zacks 2022-03-15